Author(s): Bissett SL, Wilkinson D, Tettmar KI, Jones N, Stanford E,
Abstract Share this page
Abstract Suitably controlled serosurveillance surveys are essential for evaluating human papillomavirus (HPV) immunization programs. A panel of plasma samples from 18-year-old females was assembled, the majority of the samples being from recipients of the bivalent HPV vaccine. Antibody specificities were evaluated by three independent laboratories, and 3 pools that displayed no antibodies to any HPV type tested or intermediate or high levels of antibody to HPV16, HPV18, HPV31, and HPV45 were created. These pools will be useful as control reagents for HPV serology.
This article was published in Clin Vaccine Immunol
and referenced in Journal of Proteomics & Bioinformatics